Related Experiment Video

Updated: Mar 11, 2026

Alveolar Macrophage Phagocytosis and Bacteria Clearance in Mice
11:20

Alveolar Macrophage Phagocytosis and Bacteria Clearance in Mice

Published on: March 2, 2019

12.0K

Maxed out macs: physiologic cell clearance as a function of macrophage phagocytic capacity

Clive S Zent1, Michael R Elliott2,3

  • 1Wilmot Cancer Institute, University of Rochester Medical Center, NY, USA.

The FEBS Journal
|November 19, 2016
PubMed

Insights

Macrophages efficiently clear dying or antibody-targeted cells, but physical and metabolic limits on ingestion impact overall clearance efficiency. Understanding these constraints can improve therapeutic outcomes.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Phagocytic clearance of host cells is crucial for tissue homeostasis and therapeutic interventions.
  • Macrophages are key immune cells responsible for phagocytosis.
  • While molecular recognition mechanisms are well-studied, physical and metabolic constraints on macrophage phagocytosis are less understood.

Purpose of the Study:

  • To review the physical and metabolic factors governing macrophage phagocytic capacity.
  • To explore how these factors influence the efficiency of host cell clearance.
  • To discuss leveraging this knowledge for therapeutic benefit.

Main Methods:

  • Literature review focusing on cellular material ingestion by macrophages.
  • Analysis of physical and metabolic constraints in the context of apoptotic and antibody-targeted cells.

Main Results:

  • Physical and metabolic limitations significantly affect the quantity of cellular material macrophages can ingest.
  • These constraints impact the overall efficiency of host cell clearance in various physiological and pathological conditions.

Conclusions:

  • Understanding the physical and metabolic determinants of macrophage phagocytosis is essential for optimizing cell clearance.
  • This knowledge can be applied to enhance therapeutic strategies targeting cell clearance.
Keywords:
GTPaseapoptosiscellular metabolismchronic lymphocytic leukemiaefferocytosislymphoid malignancymacrophagemonoclonal antibody therapyphagocytosis

More Related Videos

Mesenchymal Stem Cell Regulation of Macrophage Phagocytosis; Quantitation and Imaging09:10

Mesenchymal Stem Cell Regulation of Macrophage Phagocytosis; Quantitation and Imaging

Published on: July 16, 2021

3.7K
A Quantitative Assessment of the Phagocytosis of Allogeneic and Xenogeneic Erythrocytes by Rat Macrophages In Vitro09:01

A Quantitative Assessment of the Phagocytosis of Allogeneic and Xenogeneic Erythrocytes by Rat Macrophages In Vitro

Published on: August 22, 2025

553

Related Concept Videos

Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
9.3K
Clearance Models: Physiological Models01:09

Clearance Models: Physiological Models

Drug clearance is a critical pharmacokinetic process involving the irreversible removal of drugs from the body through various organs over a specified time period. Physiological models are indispensable in determining organ-specific clearance, defined by the proportion of the drug eliminated per unit of time from the organ's blood volume.
The organ's clearance rate depends on the blood flow to the organ and the extraction ratio (E). The extraction ratio describes the organ's...
398
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
5.4K
Drug Elimination: The Concept of Clearance01:06

Drug Elimination: The Concept of Clearance

Drug elimination refers to removing drugs from the body, either through urine by the kidneys or through bile by the liver. Drug clearance is a pharmacokinetic parameter that measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the plasma concentration of the drug.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
4.3K
Clearance Models: Compartment Models01:25

Clearance Models: Compartment Models

Clearance measures drug elimination from the central compartment, including plasma and highly perfused organs like kidneys and liver. Its calculation varies depending on pharmacokinetic models and administration routes. The one-compartment model, for instance, portrays the pharmacokinetics of polar drugs such as aminoglycoside antibiotics administered intravenously and readily excreted in urine. In this case, clearance is influenced by the terminal rate constant (λz) and the total volume...
1.6K
Clearance Models: Noncompartmental Models01:17

Clearance Models: Noncompartmental Models

Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
331